Baroda BNP Paribas Manufacturing Fund
(An open-ended equity scheme predominantly
investing in Manufacturing theme)
Baroda BNP Paribas Manufacturing Fund
(An open-ended equity scheme predominantly
investing in Manufacturing theme)
February 2026

February 2026


Investment Objective

The investment objective is to generate long-term capital appreciation from a portfolio invested predominantly in equity and equity related securities of companies engaged in the Manufacturing. The Scheme does not guarantee/indicate any returns. There is no assurance that the investment objective of the Scheme will be achieved.

NAV Details (As on February 27, 2026)
Regular IDCW : ₹ 10.4626
Regular Growth : ₹ 10.4626
Direct IDCW : ₹ 10.7173
Direct Growth : ₹ 10.7173
 
Benchmark Index (AMFI Tier 1)

Nifty India Manufacturing TRI

Date of Allotment

June 28, 2024

Fund Manager
Fund Manager Managing fund since Experience
Jitendra Sriram 28-Jun-24 27 years
Mr. Kushant Arora 21-Oct-24 11 years
Load Structure

Exit Load: • If units of the Scheme are redeemed or switched out up to 10% of the units within 1 year from the date of allotment - Nil. • If units of the scheme are redeemed or switched out in excess of the limit within 1 year from the date of allotment - 1% of the applicable NAV. • If units of scheme are redeemed or switched out after 1 year from the date of allotment - Nil

For detailed load structure please refer Scheme Information Document.

Lumpsum Details

Minimum Amount: Lumpsum investment:
₹ 1,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:₹ 1,000 and in multiples of ₹ 1 thereafter.


Monthly AAUM## As on February 27, 2026 : ₹ 908.00 Crores
AUM## As on February 27, 2026 : ₹ 907.24 Crores

## including inter-scheme Investments, if any, by other schemes of Baroda BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS % of Net Assets
Pharmaceuticals & Biotechnology 13.93%
Divi's Laboratories Limited 5.72%
Sun Pharmaceutical Industries Limited 3.19%
AstraZeneca Pharma India Limited 2.63%
IPCA Laboratories Limited 1.37%
Dr. Reddy's Laboratories Limited 1.02%
Automobiles 13.91%
Mahindra & Mahindra Limited 3.37%
TVS Motor Company Limited 3.28%
Maruti Suzuki India Limited 3.10%
Hero MotoCorp Limited 2.55%
Hyundai Motor India Ltd 1.61%
Electrical Equipment 11.51%
Hitachi Energy India Limited 6.85%
Bharat Heavy Electricals Limited 3.15%
ABB India Limited 1.51%
Auto Components 8.60%
ZF Commercial Vehicle Control Systems India Limited 2.11%
Bharat Forge Limited 1.90%
Bosch Limited 1.63%
Jtekt India Limited 1.63%
Tenneco Clean Air India Limited 1.33%
Petroleum Products 8.08%
Reliance Industries Limited 5.67%
Bharat Petroleum Corporation Limited 2.41%
Agricultural, Commercial & Construction Vehicles 5.98%
Tata Motors Ltd 2.51%
Escorts Kubota Limited 2.44%
BEML Limited 1.03%
Chemicals & Petrochemicals 5.47%
Linde India Limited 2.47%
Navin Fluorine International Limited 1.67%
Pidilite Industries Limited 1.33%
Diversified Metals 4.85%
Vedanta Limited 4.85%
Non - Ferrous Metals 4.01%
National Aluminium Company Limited 3.17%
Hindustan Zinc Limited 0.84%
Ferrous Metals 2.51%
JSW Steel Limited 2.51%
Construction 2.12%
Larsen & Toubro Limited 2.12%
Fertilizers & Agrochemicals 1.99%
Sumitomo Chemical India Limited 1.99%
Industrial Products 1.94%
Cummins India Limited 1.94%
Cement & Cement Products 1.88%
The India Cements Limited 1.01%
JSW Cement Limited 0.87%
Aerospace & Defense 1.63%
Bharat Electronics Limited 1.63%
Consumer Durables 1.58%
LG Electronics India Ltd 1.58%
Power 1.55%
NLC India Limited 1.55%
Diversified 1.19%
3M India Limited 1.19%
Industrial Manufacturing 1.18%
Kennametal India Limited 1.18%
LESS THAN 0.75% EXPOSURE 2.33%
FUTURES LONG POSITION 1.06%
Multi Commodity Exchange of India Limited 1.06%
TOTAL EQUITY HOLDING 97.30%
FIXED INCOME HOLDINGS Rating % of Net Assets
Treasury Bill 2.73%
364 Days Tbill (MD 19/03/2026) SOV 1.65%
364 Days Tbill (MD 25/06/2026) SOV 1.08%
Total Fixed Income Holdings 2.73%
TREPS, Cash & Other Net Current Assets -0.03%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 42.35% of the portfolio


For SIP Performance please click here

For Scheme Performance please click here

The scheme currently does not have Distribution History

TER - Regular Plan (%) 2.26%
TER - Direct Plan (%) 1.14%
Portfolio Turnover Ratio 0.52

No of Stocks 45
Portfolio RoE (%) 17.15
EPS Growth (%) 33.47

This product is suitable for investors who are seeking*:

➤ Long term capital appreciation.
➤ Investing in equity and equity related securities of companies engaged in manufacturing theme.

*Investors should consult their nancial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (Nifty India Manufacturing TRI): basis it’s constituents; As on February 27, 2026

For complete portfolio, kindly refer the website https://www.barodabnpparibasmf.in/
* refer Glossary page

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.